On May 4, 2022, Johnson & Johnson filed a complaint in the United States District Court of New Jersey against SaveOnSP over SaveOnSP’s copay maximizer program. Johnson & Johnson is seeking damages and asking the Court to prohibit SaveOnSP from continuing its maximizer program for Johnson & Johnson’s/Jansseen’s drugs. To learn more about the case read Aimed Alliance’s summary here.
Last Updated on May 22, 2022 by Aimed Alliance
